|  | 
| MechanismGABA transaminase inhibitors [+2]  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date20 Jan 1800 | 
100 Clinical Results associated with GABA-T x VAP-1 x GSK-3
100 Translational Medicine associated with GABA-T x VAP-1 x GSK-3
0  Patents (Medical) associated with GABA-T x VAP-1 x GSK-3